GERN - ジェロン (Geron Corporation) ジェロン

 GERNのチャート


 GERNの企業情報

symbol GERN
会社名 Geron Corp. (ジェロン)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 ジェロン(Geron Corporation)はJanssen Biotech Inc. (Janssen)による血液骨髄性悪性腫瘍でファーストインクラスのテロメラーゼ阻害剤、imetelstatを開発する臨床段階のバイオ医薬品会社である。同社は、腫瘍学治療薬の開発に従事している。テロメラーゼのリボ核酸(RNA)鋳型に高親和性で結合し、それによってテロメラーゼ活性を直接阻害するオリゴヌクレオチドであるように、その核酸化学を用いて、イメテスタットを設計した。JanssenはIMbarkと呼ばれる骨髄線維症(MF)の第II相試験、IMergeと呼ばれる骨髄異形成症候群(MDS)の第II / III相試験などの2つの臨床試験でImetelstatの開発に従事する。Imetelstatは、テロメラーゼのRNA鋳型に相補的であり、それと高親和性で結合するように設計され、それによってテロメラーゼ活性を直接阻害するように設計された脂質結合13merオリゴヌクレオチドである。   ジェロンは米国のバイオ医薬品会社で、抗がん剤の開発に焦点に置く。現在製品化に向け、リンパ増殖性疾患、多発性骨髄腫、非小細胞肺がん、乳がん、急性骨髄性白血病のテロメラ―ゼ阻害剤であるイメテルスタットの治験を行う。また、骨髄線維症に対するテロメラ―ゼ阻害剤の予備研究を行う。   Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.
本社所在地 149 Commonwealth Drive Suite 2070 Menlo Park CA 94025 USA
代表者氏名 Hoyoung Huh 湖寧
代表者役職名 Independent Chairman of the Board
電話番号 +1 650-473-7700
設立年月日 33178
市場名 NASDAQ National Market System
ipoyear 1996年
従業員数 42人
url www.geron.com
nasdaq_url https://www.nasdaq.com/symbol/gern
adr_tso
EBITDA EBITDA(百万ドル) -29.64000
終値(lastsale) 1.835
時価総額(marketcap) 336946417.71
時価総額 時価総額(百万ドル) 306.64880
売上高 売上高(百万ドル) 0.88000
企業価値(EV) 企業価値(EV)(百万ドル) 145.72180
当期純利益 当期純利益(百万ドル) -28.44800
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Geron Corporation revenues decreased 26% to $526K. Net loss increased 4% to $14.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Selling/General/Admin. Expense increase of 23% to $6.8M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.09 to -$0.08.

 GERNのテクニカル分析


 GERNのニュース

   Geron Secures Loan Facility for Up to $75 Million  2020/10/01 20:30:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes. “This debt financing strengthens o
   Geron to Present at the H.C. Wainwright Global Investment Conference  2020/09/09 13:00:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, to be hosted in a virtual format, on Monday, September 14, 2020 at 2:30 p.m. ET. A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you
   Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events  2020/08/06 20:05:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call today at 4:30 p.m. ET to discuss second quarter financial results and current events. “In the second quarter, we achieved a number of key milestones that have changed the trajectory of the Company,” said John A. Scarlett, M.D., Chairman and Chief Executive Offi
   Geron to Announce Second Quarter Financial Results on August 6, 2020  2020/07/30 20:30:00 Business Wire
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as recent events at 4:30 p.m. ET the same day. A live, listen-only webcast will be available on the Company’s website at www.ge
   Embarking on a Python journey? Then ‘Hands-on Machine Learning’ is a must read  2020/07/28 09:00:35 The Next Web
Writing an all-encompassing book on Python machine learning is difficult, given how expansive the field is. But reviewing one is not an easy feat either, especially when it’s a highly acclaimed title such as Hands-On Machine Learning with Scikit-Learn, Keras, and TensorFlow: Concepts, Tools, and Techniques to Build Intelligent Systems, 2nd Edition. The book is a best-seller on Amazon, and the author, Aurélien Géron, is arguably one of the most talented writers on Python machine learning. And after reading Hands-on Machine Learning, I must say that Geron does not disappoint, and the second edition is an excellent resource for Python… This story continues at The Next Web
   Geron Secures Loan Facility for Up to $75 Million  2020/10/01 20:30:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that it has entered into a loan facility for up to $75 million with Hercules Capital, Inc. (NYSE: HTGC) and Silicon Valley Bank (SVB). The loan facility provides the Company with access to non-dilutive financial resources to support the imetelstat development program, as well as working capital and general corporate purposes. “This debt financing strengthens o
   Geron to Present at the H.C. Wainwright Global Investment Conference  2020/09/09 13:00:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, to be hosted in a virtual format, on Monday, September 14, 2020 at 2:30 p.m. ET. A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you
   Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events  2020/08/06 20:05:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call today at 4:30 p.m. ET to discuss second quarter financial results and current events. “In the second quarter, we achieved a number of key milestones that have changed the trajectory of the Company,” said John A. Scarlett, M.D., Chairman and Chief Executive Offi
   Geron to Announce Second Quarter Financial Results on August 6, 2020  2020/07/30 20:30:00 Business Wire
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as recent events at 4:30 p.m. ET the same day. A live, listen-only webcast will be available on the Company’s website at www.ge
   Embarking on a Python journey? Then ‘Hands-on Machine Learning’ is a must read  2020/07/28 09:00:35 The Next Web
Writing an all-encompassing book on Python machine learning is difficult, given how expansive the field is. But reviewing one is not an easy feat either, especially when it’s a highly acclaimed title such as Hands-On Machine Learning with Scikit-Learn, Keras, and TensorFlow: Concepts, Tools, and Techniques to Build Intelligent Systems, 2nd Edition. The book is a best-seller on Amazon, and the author, Aurélien Géron, is arguably one of the most talented writers on Python machine learning. And after reading Hands-on Machine Learning, I must say that Geron does not disappoint, and the second edition is an excellent resource for Python… This story continues at The Next Web
   Geron to Present at the H.C. Wainwright Global Investment Conference  2020/09/09 13:00:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that John A. Scarlett, M.D., Chairman and Chief Executive Officer, will present a company overview at the H.C. Wainwright 22nd Annual Global Investment Conference, to be hosted in a virtual format, on Monday, September 14, 2020 at 2:30 p.m. ET. A live audio webcast of the presentation will be available on Geron’s website, www.geron.com/investors/events. If you
   Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events  2020/08/06 20:05:00 Business Wire
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today reported financial results for the second quarter ended June 30, 2020. The Company will host a conference call today at 4:30 p.m. ET to discuss second quarter financial results and current events. “In the second quarter, we achieved a number of key milestones that have changed the trajectory of the Company,” said John A. Scarlett, M.D., Chairman and Chief Executive Offi
   Geron to Announce Second Quarter Financial Results on August 6, 2020  2020/07/30 20:30:00 Business Wire
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today announced that it will release its second quarter 2020 financial results after the market closes on Thursday, August 6, 2020 via press release, which will be available on the Company’s website at www.geron.com/investors. Geron will host a conference call to discuss the financial results as well as recent events at 4:30 p.m. ET the same day. A live, listen-only webcast will be available on the Company’s website at www.ge
   Embarking on a Python journey? Then ‘Hands-on Machine Learning’ is a must read  2020/07/28 09:00:35 The Next Web
Writing an all-encompassing book on Python machine learning is difficult, given how expansive the field is. But reviewing one is not an easy feat either, especially when it’s a highly acclaimed title such as Hands-On Machine Learning with Scikit-Learn, Keras, and TensorFlow: Concepts, Tools, and Techniques to Build Intelligent Systems, 2nd Edition. The book is a best-seller on Amazon, and the author, Aurélien Géron, is arguably one of the most talented writers on Python machine learning. And after reading Hands-on Machine Learning, I must say that Geron does not disappoint, and the second edition is an excellent resource for Python… This story continues at The Next Web
   Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)  2020/07/16 12:30:00 Business Wire
MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN) today reported that it has granted a non-statutory stock option to purchase an aggregate of 150,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company. The stock option was granted on July 15, 2020 at an exercise price of $2.04 per share, which is equal to the closing price of Geron common stock on the date of grant. The stock option has a 10-

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 ジェロン GERN Geron Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)